ABCL
AbCellera BiologicsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ABCL vs peer average
79/100
ABCL vs. peer average (B vs. D)
Grade spread
B 2 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
IMCR is the first available peer comparator.
Immunocore is a closer clinical-stage biotech comp where valuation is still heavily milestone-driven, although modality and commercial maturity differ, so read-through for ABCL remains limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ABCL
AbCellera Biologics
IMCR
Immunocore American
Grade
B
F
Momentum
94
25
Value
41
48
Sentiment
32
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs IMCR
ABCL / IMCR
Grade Position
Above peers
ABCL vs. peer average (B vs. D)
79/100
Momentum
94
ABCLValue
41
IMCRSentiment
32
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ABCL
IMCR is the first peer returned for this comparison set.